Cargando…
The HMGB1 (C106A) mutation inhibits IL-10-producing CD19(hi)FcγRIIb(hi) B cell expansion by suppressing STAT3 activation in mice
Regulatory B cells have important roles in inflammation and autoimmune diseases. A newly discovered subpopulation of B cells with a CD19(hi)FcγRIIb(hi) phenotype inhibits the proliferation of CD4(+) T cells by secreting interleukin (IL)-10. The expansion of CD19(hi)FcγRIIb(hi) B cells in mouse splee...
Autores principales: | Liu, Mengru, Zhou, Jingwen, Yin, Rui, Yin, Hui, Ding, Yue, Ma, Feng, Qian, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378787/ https://www.ncbi.nlm.nih.gov/pubmed/35983056 http://dx.doi.org/10.3389/fimmu.2022.975551 |
Ejemplares similares
-
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016) -
The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019) -
Transmembrane domain dependent inhibitory function of FcγRIIB
por: Wang, Junyi, et al.
Publicado: (2018) -
FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021) -
Role of lipid nanodomains for inhibitory FcγRIIb function
por: Spiegel, Franziska, et al.
Publicado: (2023)